Pharmaceutical manufacturers are tasked with the critical responsibility of monitoring and reporting safety events to ensure patient safety and regulatory compliance. This process involves detecting, documenting, evaluating, reporting, and following up on adverse events, product quality complaints,
The biopharmaceutical industry is undergoing a significant transformation, driven by the need to develop and market novel therapies more quickly and cost-effectively. At the forefront of this revolution is WuXi Biologics, leveraging advanced Process Analytical Technology (PAT) to enhance real-time
In recent years, the healthcare industry has experienced a paradigm shift due to the rapid advancement of telemedicine technologies and the strategic investments made by pharmaceutical, medical device, and digital therapeutics (DTx) companies. The surge in telehealth investments is primarily driven
The 2024 Biopharma Technology Landscape report by Benchling, a leading R&D cloud software company, reveals the transformative impact of artificial intelligence (AI) and automation on biopharma research and development (R&D). The report highlights how large biopharma companies are leveraging these
The role of artificial intelligence (AI) in healthcare is expanding rapidly, and its application in prenatal care is proving to be a game-changer. Congenital heart defects (CHDs), the most common type of birth defect, often require early detection for timely intervention. Despite advancements in
The healthcare domain is witnessing a remarkable shift with the introduction of "TBorNotTB," a state-of-the-art clinical decision support system (CDSS) specifically designed for the evaluation of suspected tuberculosis (TB) cases in hospitals. The primary function of TBorNotTB is to aid healthcare
